Muscle Cell News 2.20 June 12, 2017 | |
![]() | |
| |
TOP STORYAntisense Oligonucleotide-Mediated Dnm2 Knockdown Prevents and Reverts Myotubular Myopathy in Mice Investigators showed that systemic delivery of Dnm2 antisense oligonucleotides (ASOs) into Mtm1 knockout mice efficiently reduces DNM2 protein level in muscle and prevents the myopathy from developing. Systemic ASO injection into severely affected mice lead to reversal of muscle pathology within two weeks. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSThe authors sought to establish an endotoxin-induced inflammatory model using human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) for mechanistic and therapeutic studies. hiPSC-CMs were treated by lipopolysaccharide in different concentrations for different times. [Sci Rep] Full Article Scientists found that placenta-derived multipotent cells (PDMCs) significantly reduced cardiomyocyte apoptosis and reactive oxygen species production through the paracrine factors GRO-α, HGF and IL-8. Moreover, culturing PDMCs on plates coated with laminin, an extracellular matrix protein, resulted in significantly enhanced secretion of all three paracrine factors, which further reduced cardiomyocyte apoptosis. [J Cell Mol Med] Full Article To assess the effects of R4344Q in vivo, researchers generated a knock-in mouse model. The expression patterns of sarcomeric and Ca2+-cycling proteins were unaltered in sedentary one-year-old knock-in myocardia, with the exception of sarco/endoplasmic reticulum Ca2+ adenosine triphosphatase 2 and pentameric phospholamban whose levels were significantly increased and decreased, respectively. Isolated cardiomyocytes from one-year-old knock-in hearts exhibited increased Ca2+-transients and Ca2+-load in the sarcoplasmic reticulum and faster contractility kinetics. [Sci Adv] Full Article SKELETAL MUSCLE CELLSNuclear Pores Regulate Muscle Development and Maintenance by Assembling a Localized Mef2C Complex The authors showed that the addition of the Nup210 nucleoporin to nuclear pore complexes (NPCs) during myoblast differentiation results in assembly of an Mef2C transcriptional complex required for efficient expression of muscle structural genes and microRNAs. They showed that this NPC-localized complex is essential for muscle growth, myofiber maturation, and muscle cell survival and that alterations in its activity result in muscle degeneration. [Dev Cell] Abstract | Press Release | Graphical Abstract Hippo pathway downstream effectors Yap and Taz play key roles in cell proliferation and regeneration, regulating gene expression especially via Tead transcription factors. To investigate their role in skeletal muscle stem cells, scientists analyzed Taz in vivo and ex vivo in comparison to Yap. [Stem Cells] Abstract Dysregulation of Nuclear Receptor COUP-TFII Impairs Skeletal Muscle Development Researchers generated a mouse model ectopically expressing chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) in myogenic precursors to maintain COUP-TFII activity during myogenesis and found that elevated COUP-TFII activity resulted in inefficient skeletal muscle development. Using in vitro cell culture and in vivo mouse models, they showed that COUP-TFII hinders myogenic development by repressing myoblast fusion. [Sci Rep] Full Article SMOOTH MUSCLE CELLSThe degeneration of vascular smooth muscle cells (SMCs) is one of the key features of thoracic aortic aneurysm and dissection. In vitro assay demonstrated that elevated mechanical stretch stimulated the endoplasmic reticulum (ER) stress response and microparticle production from both SMCs and endothelial cells (ECs) in a time-dependent manner. In vivo, administration of an ER stress inhibitor or knockout of CHOP suppressed both apoptosis of EC and the infiltration of inflammatory cells. [Clin Sci (Lond)] Full Article Chronic colonic distention mouse model, diabetic gastrointestinal paresis mouse model, cultured mouse colonic smooth muscle cells and colon specimens from Hirschsprung’s disease patients were used. Scientists showed that stem cell factor (SCF) was clearly decreased in distent colon of mice and patients, and microRNA (miR) array and real-time PCR indicated a concomitant increase of miR–34c in distent colon. [J Cell Mol Med] Full Article Vascular smooth muscle cell migration and proliferation at sites of vascular injury are both critical steps in the development of intimal hyperplasia. Local delivery of nitric oxide (NO) largely prevents these events. Cell proliferation and migration induced by platelet-derived growth factor type BB were significantly inhibited by trans-[Ru(NO)Cl(cyclam](PF6)2. [J Pharm Pharmacol] Abstract | |
| |
REVIEWSCardiac Regeneration Strategies: Staying Young at Heart Whereas damaged skeletal muscle has a profound capacity to regenerate, heart muscle, at least in mammals, has poor regenerative potential. This deficiency is attributable to the lack of resident cardiac stem cells, combined with roadblocks that limit adult cardiomyocytes from entering the cell cycle and completing division. Insights for regeneration have recently emerged from studies of animals with an elevated innate capacity for regeneration, the innovation of stem cell and reprogramming technologies, and a clearer understanding of the cardiomyocyte genetic program and key extrinsic signals. [Science] Abstract The Use of Biologics in the Management of Cardiovascular Diseases The author focuses on the use of stem cells and non-coding RNA agents to characterize the current status of these agents and describe some of the nuances that have led to the extraordinary interest in them as therapeutic agents. [Curr Opin Pharmacol] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. | |
| |
INDUSTRY NEWSCureDuchenne continues to support Dr. Kevin Flanigan from Nationwide Children’s Hospital duplication 2 mutation research to find a treatment for a rare mutation of Duchenne. CureDuchenne has funded more than $1 million to support this research over the past five years. New funding will support IND-enabling studies to complete pre-clinical data that could lead to human clinical trials in early 2018. [CureDuchenne] Press Release PTC Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Peripheral and Central Nervous Systems Drugs Advisory Committee meeting to review the new drug application for ataluren. Ataluren is an oral, first-in-class, protein restoration therapy for the treatment of nonsense mutation dystrophinopathy, including nonsense Duchenne muscular dystrophy. [PTC Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSCuriosity and Irritation Meet Macron’s Effort to Lure Foreign Scientists to France The French government unveiled a website aimed at attracting foreign scientists with four-year grants worth up to €1.5 million each. [ScienceInsider] Editorial Trump Names Sharpless to Lead U.S. Cancer Institute President Donald Trump announced his intention to appoint Norman “Ned” Sharpless to be the next director of the National Cancer Institute in Bethesda, Maryland. Sharpless, who is 50 years old, is a physician and currently director of the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill. He also holds an academic appointment at the university’s school of medicine. [ScienceInsider] Editorial
| |
EVENTSNEW Gordon Research Conferences: Biomaterials & Tissue Engineering NEW Gordon Research Conferences: Wnt Signaling Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Cardiovascular Physiology (University of Nevada, Reno) Postdoctoral Research Fellow – Muscular Dystrophy (University of Melbourne) Postdoctoral Fellow – Diabetes and Heart Disease (University Health Network) Postdoctoral Fellow – Physiology and Cell Biology (University of Nevada, Reno) Research Fellow – Cardiovascular Diseases (Mayo Clinic) Postdoctoral Position(s) – Skeletal Muscle Stem Cells (Inserm) Postdoctoral Associate – Genetics of Muscular Dystrophy (University of Florida College of Medicine) Postdoctoral/ Graduate Student Positions – Neuromuscular Diseases (University of Alberta) PhD Studentship – Experimental Genetic Cardiology (Oslo University Hospital) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|